The incidence of HER-2 expression in colon adenocarcinoma ranges from 0% to 83% [67-69] and reports on HER-2 gene amplification and HER-2 overexpression in metastatic CRC have been discordant. The gene discussed is ERBB2; the disease is colon adenocarcinoma.